GDF15 analogs as obesity therapeutics.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 36754014.
- Also identified by DOI 10.1016/j.cmet.2023.01.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There is increasing interest in GDF15 analogs as therapeutic agents for obesity. In this issue of Cell Metabolism, Benichou et al. report the first clinical trial of such a drug in obese humans.
Medical subject headings
- Obesity
- Growth Differentiation Factor 15